Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Nov;44(5):652–662. doi: 10.1038/bjc.1981.250

Prognostic value of preoperative serum CEA level compared to clinical staging. I. Colorectal carcinoma.

H J Staab, F A Anderer, T Brümmendorf, E Stumpf, R Fischer
PMCID: PMC2010833  PMID: 7317270

Abstract

In a clinical investigation of observed postoperative survival, 563 patients have been registered for primary surgical treatment of colorectal cancer since 1974. The potential prognostic factors examined within the first days of hospitalization for primary resection included age of the patients, operability, location of the tumour, tumour extension and the preoperative serum CEA level. Statistical treatment of the data revealed that each of the clinical parameters except tumour location covers ranges associated with highly significant differences in survival of the patients. The preoperative serum CEA level gave prognostic information in addition to operability or tumour extension. The prognostic significance of the preoperative CEA level was still evident when selected subgroups of patients with distinct resectability and tumour extension were examined. The results indicate that the preoperative serum CEA level is an independent prognostic parameter.

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson G. L., Zembala M. Suppressor T cells in cell-mediated immunity. Br Med Bull. 1976 May;32(2):158–164. doi: 10.1093/oxfordjournals.bmb.a071349. [DOI] [PubMed] [Google Scholar]
  2. Evans J. T., Mittelman A., Chu M., Holyoke E. D. Pre- and postoperative uses of CEA. Cancer. 1978 Sep;42(3 Suppl):1419–1421. doi: 10.1002/1097-0142(197809)42:3+<1419::aid-cncr2820420806>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  3. Fujimoto S., Greene M. I., Sehon A. H. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J Immunol. 1976 Mar;116(3):791–799. [PubMed] [Google Scholar]
  4. Goslin R., Steele G., Jr, Macintyre J., Mayer R., Sugarbaker P., Cleghorn K., Wilson R., Zamcheck N. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980 Dec;192(6):747–751. doi: 10.1097/00000658-198012000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greene M. I., Dorf M. E., Pierres M., Benacerraf B. Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5118–5121. doi: 10.1073/pnas.74.11.5118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Greene M. I., Fujimoto S., Sehon A. H. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts. J Immunol. 1977 Aug;119(2):757–764. [PubMed] [Google Scholar]
  7. Holyoke E. D., Chu T. M., Murphy G. P. CEA as a monitor of gastrointestinal malignancy. Cancer. 1975 Mar;35(3):830–836. doi: 10.1002/1097-0142(197503)35:3<830::aid-cncr2820350340>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Kohler J. P., Simonowitz D., Paloyan D. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. Am Surg. 1980 Aug;46(8):449–452. [PubMed] [Google Scholar]
  9. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Staab H. J., Anderer F. A., Stumpf E., Fischer R. Slope analysis of the postoperative CEA time course and its possible application as an aid in diagnosis of disease progression in gastrointestinal cancer. Am J Surg. 1978 Sep;136(3):322–327. doi: 10.1016/0002-9610(78)90285-4. [DOI] [PubMed] [Google Scholar]
  11. Steele G., Jr, Zamcheck N., Wilson R., Mayer R., Lokich J., Rau P., Maltz J. Results of CEA-initiated second-look surgery for recurrent colorectal cancer. Am J Surg. 1980 Apr;139(4):544–548. doi: 10.1016/0002-9610(80)90335-9. [DOI] [PubMed] [Google Scholar]
  12. Wanebo H. J., Rao B., Pinsky C. M., Hoffman R. G., Stearns M., Schwartz M. K., Oettgen H. F. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. doi: 10.1056/NEJM197808312990904. [DOI] [PubMed] [Google Scholar]
  13. Wood C. B., Ratcliffe J. G., Burt R. W., Malcolm A. J., Blumgart L. H. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer. Br J Surg. 1980 Jan;67(1):46–48. doi: 10.1002/bjs.1800670114. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES